These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

800 related articles for article (PubMed ID: 29851029)

  • 1. Placental growth factor as an indicator of fetal growth restriction in late-onset small-for-gestational age pregnancies.
    Anderson N; De Laat M; Benton S; von Dadelszen P; McCowan L
    Aust N Z J Obstet Gynaecol; 2019 Feb; 59(1):89-95. PubMed ID: 29851029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soluble fms-like tyrosine kinase to placental growth factor ratio in different stages of early-onset fetal growth restriction and small for gestational age.
    Garcia-Manau P; Mendoza M; Bonacina E; Garrido-Gimenez C; Fernandez-Oliva A; Zanini J; Catalan M; Tur H; Serrano B; Carreras E
    Acta Obstet Gynecol Scand; 2021 Jan; 100(1):119-128. PubMed ID: 32860218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Placental growth factor as a diagnostic tool for placental mediated fetal growth restriction.
    Shinar S; Tigert M; Agrawal S; Parks WA; Kingdom JC
    Pregnancy Hypertens; 2021 Aug; 25():123-128. PubMed ID: 34119877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biochemical tests of placental function versus ultrasound assessment of fetal size for stillbirth and small-for-gestational-age infants.
    Heazell AE; Hayes DJ; Whitworth M; Takwoingi Y; Bayliss SE; Davenport C
    Cochrane Database Syst Rev; 2019 May; 5(5):CD012245. PubMed ID: 31087568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ten-year experience of protocol-based management of small-for-gestational-age fetuses: perinatal outcome in late-pregnancy cases diagnosed after 32 weeks.
    Meler E; Mazarico E; Eixarch E; Gonzalez A; Peguero A; Martinez J; Boada D; Vellvé K; Gomez-Roig MD; Gratacós E; Figueras F
    Ultrasound Obstet Gynecol; 2021 Jan; 57(1):62-69. PubMed ID: 33159370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of fetal growth restriction using estimated fetal weight vs a combined screening model in the third trimester.
    Miranda J; Rodriguez-Lopez M; Triunfo S; Sairanen M; Kouru H; Parra-Saavedra M; Crovetto F; Figueras F; Crispi F; Gratacós E
    Ultrasound Obstet Gynecol; 2017 Nov; 50(5):603-611. PubMed ID: 28004439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The value of angiogenetic biomarkers in the detection of early onset fetal growth restriction.
    Giorgione V; Ramnarine S; Malik A; Bhide A
    Eur J Obstet Gynecol Reprod Biol; 2024 Aug; 299():91-95. PubMed ID: 38850897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Placental growth factor and fetoplacental Doppler indices in combination predict preterm birth reliably in pregnancies complicated by fetal growth restriction.
    Hong J; Crawford K; Cavanagh E; da Silva Costa F; Kumar S
    Ultrasound Obstet Gynecol; 2024 May; 63(5):635-643. PubMed ID: 37820083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. sFlt-1/PlGF and Doppler ultrasound parameters in SGA pregnancies with confirmed neonatal birth weight below 10th percentile.
    Kwiatkowski S; Bednarek-Jędrzejek M; Ksel J; Tousty P; Kwiatkowska E; Cymbaluk A; Rzepka R; Chudecka-Głaz A; Dołęgowska B; Torbè A
    Pregnancy Hypertens; 2018 Oct; 14():79-85. PubMed ID: 30527123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Usefulness of angiogenic factors in prenatal counseling of late-onset fetal growth-restricted and small-for-gestational-age gestations: a prospective observational study.
    Hurtado I; Bonacina E; Garcia-Manau P; Serrano B; Armengol-Alsina M; Mendoza M; Maiz N; Carreras E
    Arch Gynecol Obstet; 2023 Nov; 308(5):1485-1495. PubMed ID: 36401095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Placental growth factor as a marker of fetal growth restriction caused by placental dysfunction.
    Benton SJ; McCowan LM; Heazell AE; Grynspan D; Hutcheon JA; Senger C; Burke O; Chan Y; Harding JE; Yockell-Lelièvre J; Hu Y; Chappell LC; Griffin MJ; Shennan AH; Magee LA; Gruslin A; von Dadelszen P
    Placenta; 2016 Jun; 42():1-8. PubMed ID: 27238707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of small for gestational age neonates: screening by maternal factors, fetal biometry, and biomarkers at 35-37 weeks' gestation.
    Ciobanu A; Rouvali A; Syngelaki A; Akolekar R; Nicolaides KH
    Am J Obstet Gynecol; 2019 May; 220(5):486.e1-486.e11. PubMed ID: 30707967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fetal growth restriction and intra-uterine growth restriction: guidelines for clinical practice from the French College of Gynaecologists and Obstetricians.
    Vayssière C; Sentilhes L; Ego A; Bernard C; Cambourieu D; Flamant C; Gascoin G; Gaudineau A; Grangé G; Houfflin-Debarge V; Langer B; Malan V; Marcorelles P; Nizard J; Perrotin F; Salomon L; Senat MV; Serry A; Tessier V; Truffert P; Tsatsaris V; Arnaud C; Carbonne B
    Eur J Obstet Gynecol Reprod Biol; 2015 Oct; 193():10-8. PubMed ID: 26207980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ophthalmic artery Doppler at 35-37 weeks' gestation in pregnancies with small or growth-restricted fetuses.
    Abdel Azim S; Sarno M; Wright A; Vieira N; Charakida M; Nicolaides KH
    Ultrasound Obstet Gynecol; 2022 Apr; 59(4):483-489. PubMed ID: 35000242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biomarkers of impaired placentation at 35-37 weeks' gestation in the prediction of adverse perinatal outcome.
    Ciobanou A; Jabak S; De Castro H; Frei L; Akolekar R; Nicolaides KH
    Ultrasound Obstet Gynecol; 2019 Jul; 54(1):79-86. PubMed ID: 31100188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. sFlt-1/PlGF ratio and timing of delivery in early-onset fetal growth restriction with antegrade umbilical artery flow.
    Quezada MS; Rodríguez-Calvo J; Villalaín C; Gómez-Arriaga PI; Galindo A; Herraiz I
    Ultrasound Obstet Gynecol; 2020 Oct; 56(4):549-556. PubMed ID: 31840879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of the PLGF in the prediction of the outcome in pregnancies with a small for gestational age fetus.
    Souka AP; Antsaklis P; Tassias K; Chatziioannou MA; Papamihail M; Daskalakis G
    Arch Gynecol Obstet; 2024 Jul; 310(1):237-243. PubMed ID: 37837546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of diffusion-weighted magnetic resonance imaging of brain in fetal growth restriction: results of prospective multicenter study.
    Jouannic JM; Blondiaux E; Senat MV; Friszer S; Adamsbaum C; Rousseau J; Hornoy P; Letourneau A; de Laveaucoupet J; Lecarpentier E; Rosenblatt J; Quibel T; Mollot M; Ancel PY; Alison M; Goffinet F
    Ultrasound Obstet Gynecol; 2020 Dec; 56(6):893-900. PubMed ID: 31765031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identifying late-onset fetal growth restriction by measuring circulating placental RNA in the maternal blood at 28 weeks' gestation.
    Whitehead CL; McNamara H; Walker SP; Alexiadis M; Fuller PJ; Vickers DK; Hannan NJ; Hastie R; Tuohey L; Kaitu'u-Lino TJ; Tong S
    Am J Obstet Gynecol; 2016 Apr; 214(4):521.e1-521.e8. PubMed ID: 26880734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical implementation of the sFlt-1/PlGF ratio to identify preeclampsia and fetal growth restriction: A prospective cohort study.
    Herraiz I; Simón E; Gómez-Arriaga PI; Quezada MS; García-Burguillo A; López-Jiménez EA; Galindo A
    Pregnancy Hypertens; 2018 Jul; 13():279-285. PubMed ID: 30177066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.